Body mass index and incident cardiometabolic conditions in relation to obesity-related cancer risk: A population-based cohort study in Catalonia, Spain.


Journal

Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310

Informations de publication

Date de publication:
10 2023
Historique:
revised: 14 09 2023
received: 25 05 2023
accepted: 16 09 2023
medline: 23 10 2023
pubmed: 28 9 2023
entrez: 28 9 2023
Statut: ppublish

Résumé

We investigated the association between body mass index (BMI) and obesity-related cancer risk among individuals with/without incident hypertension (HTN), type 2 diabetes mellitus (T2DM), and cardiovascular disease (CVD) and the joint associations of overweight/obesity (BMI ≥25 kg/m A total of 38,082 individuals developed obesity-related cancers after a median of 8 years of follow-up. The positive association between BMI and obesity-related cancer risk was similar among individuals free of cardiometabolic conditions (hazard ratio, HR per 5 kg/m Public health strategies to reduce overweight can help prevent cancer cases among the general population and individuals with incident HTN/CVD. Further, weight-loss interventions seem to lead to a greater cancer risk reduction among individuals with CVD.

Sections du résumé

BACKGROUND
We investigated the association between body mass index (BMI) and obesity-related cancer risk among individuals with/without incident hypertension (HTN), type 2 diabetes mellitus (T2DM), and cardiovascular disease (CVD) and the joint associations of overweight/obesity (BMI ≥25 kg/m
RESULTS
A total of 38,082 individuals developed obesity-related cancers after a median of 8 years of follow-up. The positive association between BMI and obesity-related cancer risk was similar among individuals free of cardiometabolic conditions (hazard ratio, HR per 5 kg/m
CONCLUSIONS
Public health strategies to reduce overweight can help prevent cancer cases among the general population and individuals with incident HTN/CVD. Further, weight-loss interventions seem to lead to a greater cancer risk reduction among individuals with CVD.

Identifiants

pubmed: 37766588
doi: 10.1002/cam4.6603
pmc: PMC10587966
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20188-20200

Subventions

Organisme : Worldwide Cancer Research
ID : IIG_2019_1978
Pays : United Kingdom

Informations de copyright

© 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

Références

Circulation. 2018 Aug 14;138(7):678-691
pubmed: 29459363
Gac Sanit. 2008 May-Jun;22(3):179-87
pubmed: 18579042
Endocrinol Diabetes Nutr. 2017 Mar;64 Suppl 1:15-22
pubmed: 27543006
Am J Epidemiol. 1999 Aug 15;150(4):390-8
pubmed: 10453815
N Engl J Med. 2016 Aug 25;375(8):794-8
pubmed: 27557308
Epidemiology. 2014 May;25(3):454-61
pubmed: 24608666
Lancet. 2004 Apr 24;363(9418):1346-53
pubmed: 15110491
Am J Kidney Dis. 2006 Mar;47(3):396-405
pubmed: 16490617
Clin Epidemiol. 2019 Dec 03;11:1015-1024
pubmed: 31819655
Gut. 2020 Sep;69(9):1564-1571
pubmed: 32606208
Annu Rev Med. 2010;61:301-16
pubmed: 19824817
BMC Med. 2021 Jan 14;19(1):10
pubmed: 33441148
J Am Coll Cardiol. 2017 Jul 4;70(1):1-25
pubmed: 28527533
Lancet. 2014 Aug 30;384(9945):755-65
pubmed: 25129328
Nat Commun. 2023 Jun 30;14(1):3816
pubmed: 37391446
BMC Med Inform Decis Mak. 2017 Jan 5;17(1):2
pubmed: 28056955
Circulation. 2020 Aug 18;142(7):670-683
pubmed: 32475164
Eur J Hum Genet. 2009 Dec;17(12):1668-75
pubmed: 19491931
Epidemiology. 1999 Jan;10(1):37-48
pubmed: 9888278
Arch Intern Med. 2002 Sep 9;162(16):1867-72
pubmed: 12196085
Int J Epidemiol. 2022 Dec 13;51(6):e324-e336
pubmed: 35415748
Circulation. 2016 Mar 15;133(11):1104-14
pubmed: 26976915
Nat Rev Cancer. 2015 Aug;15(8):484-98
pubmed: 26205341
Nat Rev Cancer. 2004 Aug;4(8):579-91
pubmed: 15286738
Atherosclerosis. 2017 Aug;263:343-351
pubmed: 28624099
Cancer Med. 2023 Oct;12(19):20188-20200
pubmed: 37766588
Lancet. 2017 Mar 4;389(10072):941-950
pubmed: 28271845
Lancet. 2016 Apr 9;387(10027):1513-1530
pubmed: 27061677
Nutrients. 2021 Nov 28;13(12):
pubmed: 34959845
J Clin Invest. 2006 Jul;116(7):1793-801
pubmed: 16823477
Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2569-78
pubmed: 19755644
Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1531-43
pubmed: 12496040
BMJ. 2007 Dec 1;335(7630):1134
pubmed: 17986716
Circ Res. 2011 Sep 2;109(6):687-96
pubmed: 21885836
Nat Rev Cancer. 2011 Nov 24;11(12):886-95
pubmed: 22113164
Int J Cancer. 2022 Mar 1;150(5):782-794
pubmed: 34655476
Med Hypotheses. 2006;66(4):732-5
pubmed: 16364563
PLoS Med. 2007 Oct 16;4(10):e297
pubmed: 17941715

Auteurs

Martina Recalde (M)

Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
Universitat Autònoma de Barcelona, Bellaterra, Spain.
International Agency for Research on Cancer (IARC-WHO), Lyon Cedex, France.

Andrea Pistillo (A)

Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.

Vivian Viallon (V)

International Agency for Research on Cancer (IARC-WHO), Lyon Cedex, France.

Emma Fontvieille (E)

International Agency for Research on Cancer (IARC-WHO), Lyon Cedex, France.

Talita Duarte-Salles (T)

Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.

Heinz Freisling (H)

International Agency for Research on Cancer (IARC-WHO), Lyon Cedex, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH